Imaging Oxygen Metabolism in Acute Stroke Using MRI

Current Radiology Reports

Volumn 2, Issue 3, 2014, Pages

  An, Hongyu ^a   Ford, Andria L ^b   Vo, Katie D ^b   Liu, Qingwei ^a   Chen, Yasheng ^a   Lee, Jin Moo ^b   Lin, Weili ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BOLD; Cerebral blood flow; Ischemia; MRI; Oxygen extraction fraction; Oxygen metabolism

Indexed keywords

EID: 84930684510     PISSN: None     EISSN: 21674825     Source Type: Journal    
DOI: 10.1007/s40134-013-0039-3     Document Type: Review

References (92)

1. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768–74.
2. Astrup J, Symon L, Branston NM, Lassen NA. Cortical evoked potential and extracellular k+ and h+ at critical levels of brain ischemia. Stroke. 1977;8:51–7.
3. Astrup J. Energy-requiring cell functions in the ischemic brain. Their critical supply and possible inhibition in protective therapy. J Neurosurg. 1982;56:482–97.
4. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.
5. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D. Thrombolysis with alteplase 3–4.5 h after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.
6. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017–25.
7. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS ii). Second European–Australasian acute stroke study investigators. Lancet. 1998;352:1245–51.
8. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3–5 h after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA. 1999;282:2019–26.
9. Donnan GA, Howells DW, Markus R, Toni D, Davis SM. Can the time window for administration of thrombolytics in stroke be increased? CNS Drugs. 2003;17:995–1011.
10. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the united states: A doubling of treatment rates over the course of 5 years. Stroke. 2011;42:1952–5.
11. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, Yoo AJ, Marshall RS, Meyers PM, Yavagal DR, Wintermark M, Guzy J, Starkman S, Saver JL. A trial of imaging selection and endovascular treatment for ischemic stroke. New Engl J Med. 2013;368:914–23.
12. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO. Solitaire flow restoration device versus the merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241–9.
13. Fisher M, Takano K. The penumbra, therapeutic time window and acute ischaemic stroke. Baillieres Clin Neurol. 1995;4:279–95.
14. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508–17.
15. Davis SM, Donnan GA. Advances in penumbra imaging with MR. Cerebrovasc Dis. 2004;17(Suppl 3):23–7.
16. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7:299–309.
17. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke. 2003;34:2729–35.
18. Li F, Liu KF, Silva MD, Omae T, Sotak CH, Fenstermacher JD, Fisher M, Hsu CY, Lin W. Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats: correlation with histopathology. Stroke. 2000;31:946–54.
19. Li F, Silva MD, Liu KF, Helmer KG, Omae T, Fenstermacher JD, Sotak CH, Fisher M. Secondary decline in apparent diffusion coefficient and neurological outcomes after a short period of focal brain ischemia in rats. Ann Neurol. 2000;48:236–44.
20. Li F, Silva MD, Sotak CH, Fisher M. Temporal evolution of ischemic injury evaluated with diffusion-, perfusion-, and T^2-weighted MRI. Neurology. 2000;54:689–96.
21. Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, Saver JL. Diffusion MRI in patients with transient ischemic attacks. Stroke. 1999;30:1174–80.
22. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Kalafut M, Alger JR. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000;47:462–9.
23. Heiss WD, Sobesky J. Comparison of PET and DW/PW-MRI in acute ischemic stroke. Keio J Med. 2008;57:125–31.
24. Sobesky J, Zaro Weber O, Lehnhardt FG, Hesselmann V, Neveling M, Jacobs A, Heiss WD. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke. 2005;36:980–5.
25. Powers WJ, Grubb RL Jr, Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab. 1985;5:600–8.
26. Frykholm P, Andersson JL, Valtysson J, Silander HC, Hillered L, Persson L, Olsson Y, Yu WR, Westerberg G, Watanabe Y, Langstrom B, Enblad P. A metabolic threshold of irreversible ischemia demonstrated by PET in a middle cerebral artery occlusion–reperfusion primate model. Acta Neurol Scand. 2000;102:18–26.
27. Young AR, Sette G, Touzani O, Rioux P, Derlon JM, MacKenzie ET, Baron JC. Relationships between high oxygen extraction fraction in the acute stage and final infarction in reversible middle cerebral artery occlusion: an investigation in anesthetized baboons with positron emission tomography. J Cereb Blood Flow Metab. 1996;16:1176–88.
28. Giffard C, Young AR, Kerrouche N, Derlon JM, Baron JC. Outcome of acutely ischemic brain tissue in prolonged middle cerebral artery occlusion: a serial positron emission tomography investigation in the baboon. J Cereb Blood Flow Metab. 2004;24:495–508.
29. Powers WJ, Press GA, Grubb RL, Gado M, Raichle ME. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann Intern Med. 1987;106:27–34.
30. Powers WJ, Raichle ME. Positron emission tomography and its application to the study of cerebrovascular disease in man. Stroke. 1985;16:361–76.
31. Derdeyn CP, Videen TO, Yundt KD, Fritsch SM, Carpenter DA, Grubb RL, Powers WJ. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain. 2002;125:595–607.
32. MacKenzie ET, McGeorge AP, Graham DI, Fitch W, Edvinsson L, Harper AM. Effects of increasing arterial pressure on cerebral blood flow in the baboon: influence of the sympathetic nervous system. Pflugers Arch. 1979;378:189–95.
33. Rapela CE, Green HD. Autoregulation of canine cerebral blood flow. Circ Res. 1964;15(SUPPL):205–12.
34. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol. 1991;29:231–40.
35. Baron JC, Bousser MG, Comar D, Soussaline F, Castaigne P. Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo. Potentials, limitations, and clinical applications in cerebral ischemic disorders. Eur Neurol. 1981;20:273–84.
36. Heiss WD, Sobesky J, Hesselmann V. Identifying thresholds for penumbra and irreversible tissue damage. Stroke. 2004;35:2671–4.
37. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis. 1999;9:193–201.
38. Guadagno JV, Jones PS, Fryer TD, Barret O, Aigbirhio FI, Carpenter TA, Price CJ, Gillard JH, Warburton EA, Baron JC. Local relationships between restricted water diffusion and oxygen consumption in the ischemic human brain. Stroke. 2006;37:1741–8.
39. Heiss WD, Huber M, Fink GR, Herholz K, Pietrzyk U, Wagner R, Wienhard K. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab. 1992;12:193–203.
40. Baron JC. Pathophysiology of acute cerebral ischemia: PET studies in humans. Cerebrovasc Dis. 1991;1:22–31.
41. Pauling L, Coryell CD. The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc Natl Acad Sci USA. 1936;22:210–6.
42. Thulborn KR, Waterton JC, Matthews PM, Radda GK. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta. 1982;714:265–70.
43. Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA. 1990;87:9868–72.
44. Ogawa S, Lee TM, Barrere B. The sensitivity of magnetic resonance image signals of a rat brain to changes in the cerebral venous blood oxygenation. Magn Reson Med. 1993;29:205–10.
45. Ogawa S, Menon RS, Tank DW, Kim SG, Merkle H, Ellermann JM, Ugurbil K. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J. 1993;64:803–12.
46. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (swi). Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine. 2004;52:612–8.
47. An H, Liu Q, Chen Y, Vo KD, Ford AL, Lee JM, Lin W. Oxygen metabolism in ischemic stroke using magnetic resonance imaging. Transl Stroke Res. 2012;3:65–75.
48. • Li M, Hu J, Miao Y, Shen H, Tao D, Yang Z, Li Q, Xuan SY, Raza W, Alzubaidi S, Haacke EM. In vivo measurement of oxygenation changes after stroke using susceptibility weighted imaging filtered phase data. PLoS One. 2013;8:e63013. A SWI study to demonstrate the phase changes over time across sequential scans correlate with NIHSS change over time, suggesting a dependence of clinical outcome on the tissue oxygenation level.
49. Kavec M, Grohn OH, Kettunen MI, Silvennoinen MJ, Penttonen M, Kauppinen RA. Use of spin echo T(2) BOLD in assessment of cerebral misery perfusion at 1.5 T. Magma. 2001;12:32–9.
50. Kettunen MI, Grohn OH, Silvennoinen MJ, Penttonen M, Kauppinen RA. Quantitative assessment of the balance between oxygen delivery and consumption in the rat brain after transient ischemia with T2-BOLD magnetic resonance imaging. J Cereb Blood Flow Metab. 2002;22:262–70.
51. • Grohn OH, Kettunen MI, Penttonen M, Oja JM, van Zijl PC, Kauppinen RA. Graded reduction of cerebral blood flow in rat as detected by the nuclear magnetic resonance relaxation time T2: A theoretical and experimental approach. J Cereb Blood Flow Metab. 2000;20:316–326. T2-based BOLD was used to reveal that moderately reduced CBF leads to decreased T2, while T2 increased in regions with severely reduced CBF.
52. Grohn OH, Kauppinen RA. Assessment of brain tissue viability in acute ischemic stroke by BOLD MRI. NMR Biomed. 2001;14:432–40.
53. Grohn OH, Lukkarinen JA, Oja JM, van Zijl PC, Ulatowski JA, Traystman RJ, Kauppinen RA. Noninvasive detection of cerebral hypoperfusion and reversible ischemia from reductions in the magnetic resonance imaging relaxation time, T2. J Cereb Blood Flow Metab. 1998;18:911–20.
54. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med. 1995;34:555–66.
55. Bandettini PA, Wong EC, Jesmanowicz A, Hinks RS, Hyde JS. Spin-echo and gradient-echo EPI of human brain activation using BOLD contrast: a comparative study at 1.5 T. NMR Biomed. 1994;7:12–20.
56. De Crespigny AJ, Wendland MF, Derugin N, Kozniewska E, Moseley ME. Real-time observation of transient focal ischemia and hyperemia in cat brain. Magnetic Reson Med. 1992;27:391–7.
57. Roussel SA, van Bruggen N, King MD, Gadian DG. Identification of collaterally perfused areas following focal cerebral ischemia in the rat by comparison of gradient echo and diffusion-weighted MRI. J Cereb Blood Flow Metab. 1995;15:578–86.
58. • Tamura H, Hatazawa J, Toyoshima H, Shimosegawa E, Okudera T. Detection of deoxygenation-related signal change in acute ischemic stroke patients by T2*-weighted magnetic resonance imaging. Stroke, a journal of cerebral circulation. 2002;33:967–971. This study demonstrated reduced T2*BOLD within ischemia.
59. Wardlaw JM, von Heijne A. Increased oxygen extraction demonstrated on gradient echo (T2*) imaging in a patient with acute ischaemic stroke. Cerebrovasc Dis. 2006;22:456–8.
60. Morita N, Harada M, Uno M, Matsubara S, Matsuda T, Nagahiro S, Nishitani H. Ischemic findings of T2*-weighted 3-Tesla MRI in acute stroke patients. Cerebrovasc Dis. 2008;26:367–75.
61. • Donswijk ML, Jones PS, Guadagno JV, Carpenter TA, Moustafa RR, Fryer TD, Aigbirhio FI, Warburton EA, Baron JC. T2*-weighted MRI versus oxygen extraction fraction PET in acute stroke. Cerebrovasc Dis. 2009;28:306–313. A direct comparison between T2* BOLD and OEF measured using PET in acute stroke patients.
62. Yablonskiy DA. Quantitation of intrinsic magnetic susceptibility-related effects in a tissue matrix. Phantom study. Magn Reson Med. 1998;39:417–28.
63. •• Geisler BS, Brandhoff F, Fiehler J, Saager C, Speck O, Rother J, Zeumer H, Kucinski T. Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke. 2006;37:1778–1784. Elevated R2′ was dected in the ischemic hemisphere with the highest R2′ in ADC lesions, an increased R2′ but to a lesser degree in the lesion growth region and smallest R2′ in surviving tissue regions.
64. •• Siemonsen S, Fitting T, Thomalla G, Horn P, Finsterbusch J, Summers P, Saager C, Kucinski T, Fiehler J. T2′ imaging predicts infarct growth beyond the acute diffusion-weighted imaging lesion in acute stroke. Radiology. 2008;248:979–986. R2′ > ADC mismatch can better predict infarct growth when compared to TTP > ADC mismatch in thrombolytic treated patients.
65. Zhang J, Chen YM, Zhang YT. Blood-oxygenation-level-dependent-(BOLD-) based R2′ MRI study in monkey model of reversible middle cerebral artery occlusion. J Biomed Biotechnol. 2011;2011:318346.
66. Santosh C, Brennan D, McCabe C, Macrae IM, Holmes WM, Graham DI, Gallagher L, Condon B, Hadley DM, Muir KW, Gsell W. Potential use of oxygen as a metabolic biosensor in combination with T2*-weighted MRI to define the ischemic penumbra. J Cereb Blood Flow Metab. 2008;28:1742–53.
67. An H, Sen S, Chen Y, Powers WJ, Lin W. Noninvasive measurements of cerebral blood flow, oxygen extraction fraction, and oxygen metabolic index in human with inhalation of air and carbogen using magnetic resonance imaging. Transl Stroke Res. 2012;3:246–54.
68. Shen Q, Huang S, Du F, Duong TQ. Probing ischemic tissue fate with BOLD fMRI of brief oxygen challenge. Brain Res. 2011;1425:132–41.
69. Hu B, An HM, Shen KP, Song HY, Deng S. Polygonum cuspidatum extract induces anoikis in hepatocarcinoma cells associated with generation of reactive oxygen species and downregulation of focal adhesion kinase. Evid Based Complem Altern Med. 2012;2012:607675.
70. Shen Q, Du F, Huang S, Duong TQ. Effects of cerebral ischemic and reperfusion on T*-weighted MRI responses to brief oxygen challenge. J Cereb Blood Flow Metab. 2013.
71. •• Dani KA, Santosh C, Brennan D, McCabe C, Holmes WM, Condon B, Hadley DM, Macrae IM, Shaw M, Muir KW. T2*-weighted magnetic resonance imaging with hyperoxia in acute ischemic stroke. Ann neurol. 2010;68:37–47. This study is the first application of the T2* under oxygen challenge (OC) in clinical stroke. The DWI-defined lesion showed a reduced OC response as compared to contralateral tissue, while the presumed penumbra, imaged acutely, showed a trend of greater OC responses.
72. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med. 1994;32:749–63.
73. He X, Yablonskiy DA. Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state. Magn Reson Med. 2007;57:115–26.
74. An H, Lin W. Quantitative measurements of cerebral blood oxygen saturation using magnetic resonance imaging. J Cereb Blood Flow Metab. 2000;20:1225–36.
75. An H, Lin W. Impact of intravascular signal on quantitative measures of cerebral oxygen extraction and blood volume under normo- and hypercapnic conditions using an asymmetric spin echo approach. Magn Reson Med. 2003;50:708–16.
76. An H, Lin W. Cerebral oxygen extraction fraction and cerebral venous blood volume measurements using magnetic resonance imaging: effects of magnetic field variation. Magn Reson Med. 2001;47:958–66.
77. •• An H, Liu Q, Chen Y, Lin W. Evaluation of MR-derived cerebral oxygen metabolic index in experimental hyperoxic hypercapnia, hypoxia, and ischemia. Stroke. 2009;40:2165–2172. MROMI was used to depict the temporal evolution of cerebral oxygen metabolism during cerebral ischemia in rats subject to tMCAO.
78. He X, Zhu M, Yablonskiy DA. Validation of oxygen extraction fraction measurement by qBOLD technique. Magn Reson Med. 2008;60:882–8.
79. Christen T, Lemasson B, Pannetier N, Farion R, Segebarth C, Remy C, Barbier EL. Evaluation of a quantitative blood oxygenation level-dependent (qBOLD) approach to map local blood oxygen saturation. NMR Biomed. 2010;25(12):1340–8.
80. Altman DI, Lich LL, Powers WJ. Brief inhalation method to measure cerebral oxygen extraction fraction with PET: accuracy determination under pathologic conditions. J Nucl Med. 1991;32:1738–41.
81. Hattori N, Bergsneider M, Wu HM, Glenn TC, Vespa PM, Hovda DA, Phelps ME, Huang SC. Accuracy of a method using short inhalation of (15)o–o(2) for measuring cerebral oxygen extraction fraction with PET in healthy humans. J Nucl Med. 2004;45:765–70.
82. Sohlin MC, Schad LR. Susceptibility-related MR signal dephasing under nonstatic conditions: experimental verification and consequences for qBOLD measurements. JMRI. 2011;33:417–25.
83. Sedlacik J, Reichenbach JR. Validation of quantitative estimation of tissue oxygen extraction fraction and deoxygenated blood volume fraction in phantom and in vivo experiments by using MRI. Magn Reson Med. 2010;63:910–21.
84. An H, Liu Q, Chen Y, Lin W. Evaluation of mr-derived cerebral oxygen metabolic index in experimental hyperoxic hypercapnia, hypoxia, and ischemia. Stroke. 2009;40:2165–72.
85. Rosen BR, Turner R, Hunter GJ, Fordham JA. MR depicts perfusion of brain and heart. Diagn Imaging (San Franc). 1991;13:105–10.
86. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab. 1996;16:1236–49.
87. Wong EC, Buxton RB, Frank LR. Quantitative perfusion imaging using arterial spin labeling. Neuroimaging Clin N Am. 1999;9:333–42.
88. Detre JA, Samuels OB, Alsop DC, Gonzalez-At JB, Kasner SE, Raps EC. Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis. J Magn Reson Imaging. 1999;10:870–5.
89. Lee JM, Vo KD, An H, Celik A, Lee Y, Hsu CY, Lin W. Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol. 2003;53:227–32.
90. •• Lin W, An H, Ford AL, Chen Y, Vo KD, Powers WJ, Lee JM. MR imaging of oxygen extraction and neurovascular coupling. Stroke; a journal of cerebral circulation. 2013;44:S61–64. MROMI in stroke patients.
91. •• An H, Ford AL, Chen Y, Vo K, Powers WJ, Lee JM, Lin W. MR oxygenmetabolic index (omi) thresholds for delineating core, penumbra, and oligemia in acute ischemic stroke patients. Int Stroke Conf. 2013:181. This study derived a pair of MROMI thresholds to define core, penumbra and oligemia.
92. •• Lee JM, Ford AL, An H, Chen Y, Vo K, Powers WJ, Lin W. Mr-oxygen metabolic index (OMI) is superior to diffusion-perfusion mismatch for predicting tissue fate in the ischemic penumbra. Int Stroke Conf. 2013:12. This study demonstrated that MROMI outperforms DPM in predicting tissue fate in the ischemic penumbra.